885518-25-2 Usage
Uses
Used in Pharmaceutical Industry:
1H-Indol-4-amine,6-fluoro-(9CI) is used as a potential drug candidate for the development of new pharmaceuticals due to its promising pharmacological properties. Its unique structure allows it to be a versatile intermediate in the synthesis of various pharmaceuticals.
Used in Anticancer Agents Development:
In the realm of oncology, 1H-Indol-4-amine,6-fluoro-(9CI) is utilized as an intermediate in the creation of anticancer agents. Its specific chemical structure may contribute to the development of compounds that can target and combat cancer cells.
Used in Antimicrobial Agents Development:
Beyond oncology, 1H-Indol-4-amine,6-fluoro-(9CI) also serves as a building block in the development of antimicrobial agents. Its properties may be harnessed to create new antibiotics or antifungal drugs, addressing the need for novel treatments in light of increasing antibiotic resistance.
Used as a Research Chemical:
1H-Indol-4-amine,6-fluoro-(9CI) is also used as a research chemical, enabling scientists to study its biological activity. This research is crucial for understanding the compound's potential therapeutic applications and for furthering knowledge in medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 885518-25-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,5,1 and 8 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 885518-25:
(8*8)+(7*8)+(6*5)+(5*5)+(4*1)+(3*8)+(2*2)+(1*5)=212
212 % 10 = 2
So 885518-25-2 is a valid CAS Registry Number.
885518-25-2Relevant academic research and scientific papers
CYANOINDOLINE DERIVATIVES AS NIK INHIBITORS
-
Page/Page column 246, (2018/02/03)
Fused aromatic bicyclic substituted 5-(2-amino-4-pyrimidinyl)- cyanoindoline derivatives (I) useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-KB-inducing kinase (NIK - also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.
MINERALOCORTICOID RECEPTOR ANTAGONISTS
-
, (2012/08/07)
Disclosed are the compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, which are useful for treating aldosterone-mediated diseases. The processes for preparing compounds of the Formula (I), the use for the therapy and prophyl
